Skip to main content

Table 2 The pooled analysis of OS from different NCBD database studies

From: Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response

Hazard ratio of OS

5-years OS rate

Study

HR

95% CI

I2 (%)

P

Study

OR

95% CI

I2

P

LCI

UCI

LCI

UCI

All [18, 26, 29, 31, 35, 38, 39, 43, 47] 

0.65

0.57

0.74

46

 < 0.001*

All [18, 26, 29, 31, 35, 38, 39, 43]

1.890

1.623

2.198

49.8

 < 0.001*

Lai et al. [19]

0.803

0.678

0.952

0

0.011

Lai et al [19] 

1.605

1.182

2.179

39.3

0.002*

Bliggenstorfer et al. [26] 

0.756

0.633

0.903

25.8

0.002

Bliggenstorfer et al. [26]

1.626

1.179

2.242

43

0.003*

Naffouje et al. [29] 

0.812

0.716

0.921

0

0.001

Naffouje et al. [29] 

1.543

1.159

2.053

34.9

0.003*

Morris et al. [18] 

0.776

0.658

0.914

0

0.002

Morris et al. [18] 

1.600

1.185

2.160

38.7

0.002*

Gahagan et al. [31]

0.790

0.694

0.9

0

 < 0.001

Gahagan et al. [31]

1.546

1.175

2.033

34.9

0.002*

Dossa et al. [35] 

0.774

0.648

0.925

13.9

0.005

Dossa et al. [35]

1.626

1.175

2.252

43

0.003*

Polanco et al. [38]

0.662

0.577

0.76

36

 < 0.001

Polanco et al. [38]

1.616

1.176

2.222

41.1

0.003*

Turner et al. [39] 

0.831

0.729

0.947

0

0.005

Turner et al. [39] 

1.567

1.189

2.066

35.4

0.001*

Shahab et al. [43] 

0.82

0.68

0.98

0

0.031

Shahab et al. [43]

1.650

1.168

2.331

52.1

0.004*

Xu et al. [47] 

0.784

0.654

0.941

13.9

0.009

      
  1. *random effects model; HR hazard ratio, OR odds ratio, CI confidence interval, LCI low confidence interval, UCI upper confidence interval, OS overall survival